Consider the drug DES described in the Discussion Case that opened this chapter. In this case, a product proved defective during normal use. Hundreds of women got cancer because of a drug that their mothers took and which may have actually facilitated their -own birth. Given all that was known about the drug, it would be unreasonable to accuse either the manufacturers who made the drug, the physicians who prescribed it, the pharmacists who sold it, or the women who used it of negligence. No one could have reasonably foreseen the harm that was being caused by this drug. Nevertheless, as in all strict products liability cases, there were victims in this case and someone must be accountable for these harms.